ETPrime

Concord Biotech Share Price

  • 1,621.95-22.00 (-1.34%)
  • Volume: 77,112
  • Closed
  • Last Updated On: 12 Mar, 2025, 03:42 PM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...

Concord Biotech Share Price

  • 1,621.95-22.00 (-1.34%)
  • Volume: 77,112
Advertisment

Stock Recommendations

  • Potential
    Upside

  • 1 Year
    Target

BUY

Mean Recos by
4 Analysts

0

0

2

1

1

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside

Stock Reports Plus

5/10

Stock Score

View Report
Earnings
1
Fundamentals
7
Relative Valuation
2
Risk
7
Price Momentum
10
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Concord Biotech share price insights

  • Company has spent less than 1% of its operating revenues towards interest expenses and 12.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Concord Biotech Ltd. share price moved down by -1.34% from its previous close of Rs 1,643.95. Concord Biotech Ltd. stock last traded price is 1,621.95

    Share PriceValue
    Today/Current/Last1,621.95
    Previous Day1,643.951,647.40

InsightsConcord Biotech

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		52.01
    EPS - TTM
    (₹)    		31.19
    MCap
    (₹ Cr.)    		16,968.23
    Sectoral MCap Rank
    		28
    PB Ratio
    (x)    		11.27
    Div Yield
    (%)    		0.54
    Face Value
    (₹)    		1.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    		-
    VWAP
    (₹)    		1,603.88
    52W H/L
    (₹)
    2,664.00 / 1,327.05

    Concord Biotech Ltd. Share Price Returns

    1 Day-1.34%
    1 Week-7.18%
    1 Month-23.46%
    3 Months-24.29%
    1 Year14.36%
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Concord Biotech Ltd. belongs to analysts' top-rated companies list?

    View Stock Screeners

    Concord Biotech News & Analysis

    View all Concord Biotech Share News & Announcements

    Concord Biotech Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 4 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy

    That's all for Concord Biotech recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy1111
    Buy1111
    Hold2221
    Sell----
    Strong Sell----
    # Analysts4443
    View all Stock Recommendations

    Concord Biotech Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 12.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
      Total Income258.95320.21226.11329.78248.98
      Total Income Growth (%)-19.1341.62-31.4432.45-7.94
      Total Expenses159.53186.82147.70198.40148.40
      Total Expenses Growth (%)-14.6126.48-25.5533.69-5.14
      EBIT99.42133.3978.41131.38100.58
      EBIT Growth (%)-25.4770.12-40.3230.63-11.79
      Profit after Tax (PAT)75.9295.7459.5995.0277.57
      PAT Growth (%)-20.7060.66-37.2822.49-4.25
      EBIT Margin (%)38.3941.6634.6839.8440.40
      Net Profit Margin (%)29.3229.9026.3628.8131.16
      Basic EPS (₹)7.269.155.709.087.41
      Quarterly | AnnualDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
      Total Income258.95320.21226.11329.78248.98
      Total Income Growth (%)-19.1341.62-31.4432.45-7.94
      Total Expenses159.53186.82147.70198.40148.40
      Total Expenses Growth (%)-14.6126.48-25.5533.69-5.14
      EBIT99.42133.3978.41131.38100.58
      EBIT Growth (%)-25.4770.12-40.3230.63-11.79
      Profit after Tax (PAT)74.0998.7058.2497.2174.55
      PAT Growth (%)-24.9369.47-40.0930.40-11.77
      EBIT Margin (%)38.3941.6634.6839.8440.40
      Net Profit Margin (%)28.6130.8225.7629.4829.94
      Basic EPS (₹)7.089.435.579.297.13
      Quarterly | Annual FY 2024 FY 2023
      Total Revenue1,050.72888.48
      Total Revenue Growth (%)18.2620.66
      Total Expenses641.53568.42
      Total Expenses Growth (%)12.8614.79
      Profit after Tax (PAT)308.10240.09
      PAT Growth (%)28.3337.25
      Operating Profit Margin (%)40.4838.04
      Net Profit Margin (%)30.2928.14
      Basic EPS (₹)29.4522.95
      Quarterly | Annual FY 2024
      Total Revenue1,050.72
      Total Revenue Growth (%)18.26
      Total Expenses641.53
      Total Expenses Growth (%)12.86
      Profit after Tax (PAT)304.73
      PAT Growth (%)27.97
      Operating Profit Margin (%)40.48
      Net Profit Margin (%)29.96
      Basic EPS (₹)29.13

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023
      Total Assets1,700.711,513.98
      Total Assets Growth (%)12.3315.33
      Total Liabilities174.06223.98
      Total Liabilities Growth (%)-22.296.88
      Total Equity1,526.651,290.00
      Total Equity Growth (%)18.3416.93
      Current Ratio (x)6.303.79
      Total Debt to Equity (x)0.000.02
      Contingent Liabilities26.7526.59
      Annual FY 2024
      Total Assets1,699.32
      Total Assets Growth (%)12.19
      Total Liabilities174.06
      Total Liabilities Growth (%)-21.83
      Total Equity1,525.25
      Total Equity Growth (%)18.06
      Current Ratio (x)6.30
      Total Debt to Equity (x)0.00
      Contingent Liabilities26.75

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 154.61 cr for investing activities which is an YoY decrease of 2.12%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023
      Net Cash flow from Operating Activities265.47246.00
      Net Cash used in Investing Activities-154.61-157.95
      Net Cash flow from Financing Activities-99.21-85.22
      Net Cash Flow11.642.83
      Closing Cash & Cash Equivalent15.143.50
      Closing Cash & Cash Equivalent Growth (%)332.73424.70
      Total Debt/ CFO (x)0.020.13
      Annual FY 2024
      Net Cash flow from Operating Activities265.47
      Net Cash used in Investing Activities-154.61
      Net Cash flow from Financing Activities-99.21
      Net Cash Flow11.64
      Closing Cash & Cash Equivalent15.14
      Closing Cash & Cash Equivalent Growth (%)332.73
      Total Debt/ CFO (x)0.02

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023
      Return on Equity (%)20.1818.61
      Return on Capital Employed (%)26.4124.54
      Return on Assets (%)18.1115.85
      Interest Coverage Ratio (x)182.3583.94
      Asset Turnover Ratio (x)0.630.60
      Price to Earnings (x)51.81-
      Price to Book (x)10.43-
      EV/EBITDA (x)34.13-
      EBITDA Margin (%)45.7544.37
      Annual FY 2024
      Return on Equity (%)19.97
      Return on Capital Employed (%)26.44
      Return on Assets (%)17.93
      Interest Coverage Ratio (x)182.35
      Asset Turnover Ratio (x)0.63
      Price to Earnings (x)52.36
      Price to Book (x)10.44
      EV/EBITDA (x)34.13
      EBITDA Margin (%)45.75

    Financial InsightsConcord Biotech

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 12.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 154.61 cr for investing activities which is an YoY decrease of 2.12%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Concord Biotech Share Price Forecast

    • Get multiple analysts’ prediction on Concord Biotech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Concord Biotech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Concord Biotech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Concord Biotech Technicals

    • Bullish / Bearish signals for Concord Biotech basis selected technical indicators and moving average crossovers.

      5 Day EMA Crossover

      Bearish signal on daily chart

      Appeared on: 10 Mar 2025

      5D EMA: 1695.93

      Last 4 Sell Signals:10 Feb 2025
      Date7 days Gain/Loss %
      10 Feb 2025-33.67%
      15 Jan 2025-7.01%
      1 Jan 2025-3.41%
      19 Dec 2024-1.37%

      Average price decline of -3.95% within 7 days of Bearish signal in last 5 years

      10 Day EMA Crossover

      Bearish signal on daily chart

      Appeared on: 10 Mar 2025

      10D EMA: 1700.44

      Last 4 Sell Signals:11 Feb 2025
      Date7 days Gain/Loss %
      11 Feb 2025-30.43%
      1 Feb 2025-2.37%
      16 Jan 2025-6.50%
      1 Jan 2025-3.41%

      Average price decline of -4.61% within 7 days of Bearish signal in last 5 years

    • 45%
      Positive Movement since
      1st Jan 2005 on basis
      55%
      Negative Movement since
      1st Jan 2005 on basis
      Exclude

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic1677.551711.151767.901654.401620.801597.651540.90

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR91.14111.35110.30

    Concord Biotech Ltd. Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Concord Biotech Ltd.52.0111.1120.1826.4118.110.0040.4829.9629.456.300.000.02
          Suven Pharma 105.5714.3714.6419.2413.322.8039.2928.5611.8011.820.020.11
          Syngene Int.54.316.4011.9713.568.2916.5719.4614.6112.711.710.030.14
          Piramal Pharma687.823.380.225.760.118.727.72-0.500.141.250.584.54
          Gland Pharma36.932.988.8512.507.2417.3020.4513.6346.904.040.040.32
          Add More
          Annual Ratios (%)

          Choose from Peers

          • J B Chemicals
          • Wockhardt
          • Emcure Pharmaceuticals Ltd.
          • Eris Lifesciences
          • Neuland Labs

          Choose from Stocks

            See All Parameters

          Peers InsightsConcord Biotech

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Concord Biotech Shareholding Pattern

            • Loading...
              Showing Concord Biotech Shareholding as on Dec 2024
              CategoryDec 2024Sep 2024Jun 2024Mar 2024
              Promoters44.0844.0844.0844.08
              Pledge0.000.000.000.00
              FII8.338.107.116.48
              DII9.589.8210.358.41
              Mutual Funds4.864.975.265.15
              Others38.0138.0038.4641.03
            • Showing Shareholding as on Dec 2024
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters4,61,16,35644.08 %0.00
              Pledge00.00 %0.00
              FII87,18,3488.33 %0.23
              DII1,00,31,6079.58 %-0.24
              MF50,88,9434.86 %-0.10
              Others3,97,49,89338.01 %0.01

            Concord Biotech MF Ownership

            MF Ownership details are not available.

            Top Searches:
            Concord Biotech Ltd. News Concord Biotech Ltd. Quarterly Results Concord Biotech Ltd. Dividend Concord Biotech Ltd. Q1 ResultsConcord Biotech Ltd. Q2 ResultsConcord Biotech Ltd. Q3 ResultsConcord Biotech Ltd. Q4 Results

            Concord Biotech Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Feb 13, 2025Jan 24, 2025Board MeetingQuarterly Results
              Nov 11, 2024Nov 06, 2024Board MeetingQuarterly Results
              Aug 09, 2024Jul 31, 2024Board MeetingQuarterly Results
              Jun 29, 2024Jun 14, 2024AGMBook closure from Jun 23, 2024 to Jun 29, 2024
              May 23, 2024May 15, 2024Board MeetingAudited Results & Dividend
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final875%8.75Jun 21, 2024May 23, 2024

            • No other corporate actions details are available.

            About Concord Biotech

            Concord Biotech Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 17,085.92 Crore) operating in Pharmaceuticals sector. Concord Biotech Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives and Sale of services for the year ending 31-Mar-2023. Show More

            • Executives

            • Auditors

            • SV

              Sudhir Vaid

              Chairman & Managing Director
              AV

              Ankur Vaid

              Joint Managing Director & CEO
              RA

              Rajiv Ambrish Agarwal

              Non Executive Director
              RK

              Ravi Kapoor

              Non Executive Director
              Show More
            • Deloitte Haskins & Sells

            Industry

            Pharma - Indian

            Key Indices Listed on

            Nifty 500, BSE 500, BSE 250 SmallCap Index, + 9 more

            Address

            1482-1486, Trasad Road,Dholka,Ahmedabad, Gujarat - 382225

            Contact

            [email protected]

            http://www.concordbiotech.com

            More Details

            FAQs about Concord Biotech share

            • 1. What is Concord Biotech Ltd. share price and what are the returns for Concord Biotech Ltd. share?
              Concord Biotech Ltd. share price is Rs 1,621.95 as on 12 Mar, 2025, 03:57 PM IST. Concord Biotech Ltd. share price is down by 1.34% based on previous share price of Rs 1,677.05. Concord Biotech Ltd. share price trend:
              • Last 1 Month: Concord Biotech Ltd. share price moved down by 23.46%
              • Last 3 Months: Concord Biotech Ltd. share price moved down by 24.29%
              • Last 12 Months: Concord Biotech Ltd. share price moved up 14.36%
              • Last 3 Years: Concord Biotech Ltd. Share price moved remain unchanged by N.A.
            • 2. What are the returns for Concord Biotech Ltd. share?
              Return Performance of Concord Biotech Ltd. Shares:
              • 1 Week: Concord Biotech Ltd. share price moved down by 7.18%
              • 1 Month: Concord Biotech Ltd. share price moved down by 23.46%
              • 3 Month: Concord Biotech Ltd. share price moved down by 24.29%
              • 6 Month: Concord Biotech Ltd. share price moved down by 19.09%
            • 3. Who's the owner of Concord Biotech Ltd.?
              Promoter, DII and FII owns 44.08, 9.82 and 8.1 shares of Concord Biotech Ltd. as on 31 Dec 2024
              • There is no change in promoter holding from 30 Sep 2024 to 31 Dec 2024
              • Domestic Institutional Investors holding have gone down from 9.82 (30 Sep 2024) to 9.58 (31 Dec 2024)
              • Foreign Institutional Investors holding has gone up from 8.1 (30 Sep 2024) to 8.33 (31 Dec 2024)
              • Other investor holding has gone up from 38.0 (30 Sep 2024) to 38.01 (31 Dec 2024)
            • 4. What are the Concord Biotech Ltd. quarterly results?
              Total Revenue and Earning for Concord Biotech Ltd. for the year ending 2024-03-31 was Rs 1050.72 Cr and Rs 308.10 Cr on Consolidated basis. Last Quarter 2024-12-31, Concord Biotech Ltd. reported an income of Rs 258.95 Cr and profit of Rs 75.92 Cr.
            • 5. Who is the CEO of Concord Biotech Ltd.?
              Ankur Vaid is the Joint Managing Director & CEO of Concord Biotech Ltd.
            • 6. What has been highest price of Concord Biotech Ltd. share in last 52 weeks?
              52 Week high of Concord Biotech Ltd. share is Rs 2,664.00 while 52 week low is Rs 1,327.05
            • 7. What is the PE & PB ratio of Concord Biotech Ltd.?
              The PE ratio of Concord Biotech Ltd. stands at 52.71, while the PB ratio is 11.27.
            • 8. How can I quickly analyze Concord Biotech Ltd. stock?
              Key Metrics for Concord Biotech Ltd. are:
              • PE Ratio of Concord Biotech Ltd. is 52.01
              • Price/Sales ratio of Concord Biotech Ltd. is 15.66
              • Price to Book ratio of Concord Biotech Ltd. is 11.27
            • 9. What's the market capitalization of Concord Biotech Ltd.?
              Concord Biotech Ltd. share has a market capitalization of Rs 16,968.23 Cr. Within Pharmaceuticals sector, it's market cap rank is 28.
            • 10. Who is the chairman of Concord Biotech Ltd.?
              Sudhir Vaid is the Chairman & Managing Director of Concord Biotech Ltd.
            • 11. Who are peers to compare Concord Biotech Ltd. share price?
              Within Pharmaceuticals sector Concord Biotech Ltd., Emcure Pharmaceuticals Ltd., Gland Pharma Ltd., Natco Pharma Ltd., J B Chemicals & Pharmaceuticals Ltd., Wockhardt Ltd., Eris Lifesciences Ltd., Suven Pharmaceuticals Ltd., Syngene International Ltd., Piramal Pharma Ltd. and Neuland Laboratories Ltd. are usually compared together by investors for analysis.
            • 12. Is Concord Biotech Ltd. a good buy?
              As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 4 analysts for Concord Biotech Ltd. stock is to Buy. Recommendation breakup is as follows
              • 1 analyst is recommending Strong Buy
              • 1 analyst is recommending to Buy
              • 2 analysts are recommending to Hold

            Trending in Markets

            Top Gainers As on 03:59 PM | 12 Mar 2025

            Balrampur Chini486.95
            36.35 (8.07%)
            KEC Int.714.60
            37.90 (5.61%)
            BSE4,014.40
            204.66 (5.38%)
            NLC India 229.31
            10.04 (4.58%)
            IndusInd Bank684.70
            28.75 (4.39%)

            Top Losers As on 03:59 PM | 12 Mar 2025

            Indegene522.55
            -55.00 (-9.53%)
            Firstsource306.80
            -24.56 (-7.41%)
            Bharti Hexacom1,357.40
            -92.25 (-6.37%)
            L&T Tech4,390.65
            -252.11 (-5.43%)
            Anand Rathi Wealth1,652.85
            -86.36 (-4.97%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Concord Biotech Ltd. Share Price
            The Economic Times
            BrowseCompanies: